Hutto Wesley M, Schroeder Paul B, Leggit Jeffery C
School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD.
Department of Family Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD.
Mil Med. 2019 May 1;184(5-6):e458-e461. doi: 10.1093/milmed/usy223.
Chronic exertional compartment syndrome (CECS) is a debilitating condition that is not uncommon in athletes and military service members. The only curative treatment for this condition, surgical fascial release, was first described in 1956. In the ensuing 62 years, this has remained the standard therapy despite symptom recurrence in 45% of military service members who underwent surgery. In 2013, a case series introduced intracompartmental injections of botulinum toxin A as a non-surgical treatment option for CECS, which proved effective in 15 out of 16 patients. In this case report, we present the case of a U.S. military service member treated with BoNT-A for bilateral lower leg CECS. This patient remains pain free at 11 months after initial treatment. This case, coupled with previously published cases series, demonstrates the potential of this novel treatment as a long-term, non-surgical alternative for CECS in the U.S. military population.
慢性运动性骨筋膜室综合征(CECS)是一种使人衰弱的病症,在运动员和军人中并不罕见。针对这种病症的唯一治愈性治疗方法——手术筋膜松解术,于1956年首次被描述。在随后的62年里,尽管接受手术的军人中有45%出现症状复发,但这仍然是标准治疗方法。2013年,一个病例系列介绍了在骨筋膜室内注射A型肉毒杆菌毒素作为CECS的一种非手术治疗选择,16例患者中有15例证明有效。在本病例报告中,我们介绍了一名接受A型肉毒杆菌毒素治疗双侧小腿CECS的美国军人的病例。该患者在初始治疗11个月后仍无疼痛。该病例与先前发表的病例系列相结合,证明了这种新治疗方法作为美国军人CECS的长期非手术替代方法的潜力。